title: 26th Bethesda conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities. Task Force 3: hypertrophic cardiomyopathy, myocarditis and other myopericardial diseases and mitral valve prolapse.
authors.forename: B J
authors.initials: BJ
authors.lastname: Maron
authors.forename: J M
authors.initials: JM
authors.lastname: Isner
authors.forename: W J
authors.initials: WJ
authors.lastname: McKenna
mesh_terms: D009202:Cardiomyopathies / Q000175:diagnosis*; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis*; D004608:Eligibility Determination; D006801:Humans; D008945:Mitral Valve Prolapse / Q000175:diagnosis*; D009205:Myocarditis / Q000175:diagnosis*; D010493:Pericarditis / Q000175:diagnosis*; D012306:Risk; D013177:Sports; D013178:Sports Medicine